Sector
Finance Wales further supports iVision UK with £700,000
Finance Wales has further invested £700,000 in LED manufacturer iVision UK.
T-Venture invests in software company Jcom1 AG
-Venture, the venture capital subsidiary of Deutsche Telekom, has invested in BPM specialist Jcom1 AG.
Octopus leads £3m round for Mi-Pay
Octopus Ventures has led a £3m investment round for Mi-Pay, a processor of payments for the mobile money sector.
Kelso Place acquires LGV from administration
Kelso Place Asset Management has acquired, as a going concern, the business and assets of driving instructor training company LGV Limited from administration in a deal of undisclosed value.
3i makes 3.5x money on Ambea sale to Triton
3i has divested its stake in healthcare and care services provider Ambea in a €850m secondary buyout to Triton.
HgCapital reaps 2.3x return on Hoseasons trade sale
HgCapital has agreed to sell self-catering holiday operator Hoseasons Holdings Ltd to Wyndham Exchange & Rentals for an enterprise value of £51m.
Maven invests £1.5m in PrismTech
Maven Capital Partners, as a joint manager of government-backed Capital for Enterprise Fund (CfE Fund), has invested £1.5m in Scottish software firm PrismTech.
Russia Partners and Bessemer Venture Partners invest in Parallels
Russia Partners, an affiliate of Siguler Guff, and Bessemer Venture Partners have invested in software company Parallels.
Explorer's Gascan buys network operations in Portugal for €1.5m
Explorer Investments-backed Gascan, a propane gas distributor, has spent €1.5m acquiring various network operators in Portugal.
PAI interested in dairy producer Ebro Puleva
PAI Partners has reportedly expressed interest in acquiring Spanish dairy producer Ebro Puleva.
3i-led consortium favourite bidder for E.ON Italian gas grid
According to reports, a 3i-led consortium, which includes Italian gas supplier Erogasmet, has been selected by E.ON for the acquisition of its Italian gas grid; the deal has been estimated at over €300m.
Chalmers backs Orthocone with SEK 850,000
Chalmers Innovation Seed Fund has invested SEK 850,000 in technology start-up Orthocone.
Inflexion completes £28.4m take-private of FDM Group
Inflexion Private Equity has completed the de-listing of IT services company FDM Group. The deal valued the AIM-listed business at £28.4m, down from £33.3m, as reported in unquote" in December last year, when the deal was agreed.
Green spark: Renewables still generating returns
Despite the difficult economic backdrop, environmental infrastructure continues to prove attractive to investors. By Francinia Protti-Alvarez
BOCE acquires Austria Email from UIAG
Buy-Out Central Europe has acquired 63.41% of listed Austria Email AG from investor UIAG.
Phoenix nearly triples money on Nationwide sale to Halfords
Second exit in 2010 for Phoenix, Kimberly Romaine reports
Nauta in €1.5m round for Abiquo
Venture firm Nauta has led a €1.5m round for technology firm Abiquo, contributing €1m to the round and closing the first deal of its third fund Nauta III.
Novartis Ventures et al. in £8.65m round for ITS
Novartis Ventures, Sweden’s HealthCap, France’s Truffle Capital and London Technology Fund, have participated in a £8.65m funding round for British biotech company Immune Targeting Systems (ITS).
Q&A: Early-stage evolution
Bart Diels, partner at Belgian investor Gimv, speaks to Francinia Protti-Alvarez about how the venture market in the Benelux region has adapted to the changing economic climate.
KBC and ARKimedes invest in Concrete Systems
KBC Private Equity and ARKimedes through their joint subsidiary KBC Arkiv, have invested an undisclosed sum in shuttering solutions manufacturer Concrete System.
PTV and Sunstone invest €2.5m in Layar
Prime Technology Ventures (PTV) has together with Sunstone Capital, led a €2.5m series A round for Dutch augmented reality (AR) platform provider Layar.
High-Tech Gründerfonds et al. invest in design2desire
High-Tech Gründerfonds has led a funding round in design furniture maker design2desire.
EQT's Actavis still in the race for for ratiopharm
According to reports, EQT-backed Actavis is still left in the race for generic drugs group ratiopharm being sold by VEM Vermoegensverwaltung GmbH.